En Es
Categories

Industry News

Global Contrast Injectors Market Driven by Increasing Chronic Diseases

By Medimaging International staff writers
10 Jul 2018

Image: The global contrast injectors market is expected to grow over 5% during 2018-2022, driven primarily by increasing chronic diseases (Photo courtesy of Mallinckrodt/Guerbet).The global contrast injectors market is expected to grow at a CAGR of 5.07% over the forecast period 2018-2022, driven primarily by increasing chronic diseases. In recent years, there has been a significant increase in the demand for medical devices such as contrast injectors for treating such chronic illness arising from the growing incidence of cardiovascular diseases as a result of obesity and increase in blood pressure. These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

A key trend in the market is the growing demand for automated contrast injectors. A number of technological advances are taking place in contrast media injector systems such as the development of automated contrast injectors, dual head, syringe-less and triple head contrast injectors, and integration of the device with the patients' database. Increasing awareness of information technology in the healthcare sector is resulting in vendors in the contrast injectors market focusing on integrating these contrast media injectors with IT systems including hospital information system (HIS), and picture archiving and communication systems (PACS). However, the high cost of contrast media injectors poses a key challenge to market growth.

Related Links:
Research and Markets



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 Feb 2019
RSNA Debuts New Journal Focused on AI in Radiology
The Radiological Society of North America has published the first issue of its new online journal, Radiology: Artificial Intelligence.
Read More
20 Feb 2019
Researchers Publish Chest X-Ray Dataset to Train AI Models
Researchers from the Stanford University School of Medicine have published CheXpert, a large dataset of chest X-rays and competition for automated chest X-ray interpretation, which features uncertainty labels and radiologist-labeled reference standard evaluation sets.
Read More
20 Feb 2019
ECR 2019 Debuts Artificial Intelligence Exhibition
The Artificial Intelligence Exhibition (AIX) made its grand debut at the 2019 European Congress of Radiology (ECR) annual meeting held on Feb. 27-March 3 in Vienna, Austria, bringing AI to the heart of the technical exhibition.
Read More
20 Feb 2019
AI-based Software for Chest X-rays Receives CE Certification
Oxipit, a provider of AI-based medical imaging solutions, has received CE certification for its ChestEye radiology imaging suite.
Read More
20 Feb 2019
Alliance for AI in Healthcare Formally Launched
The Alliance for Artificial Intelligence in Healthcare was formally launched following the inaugural meeting of its 22-person board of directors.
Read More
20 Feb 2019
Global Digital Pathology Market to Reach USD 600 Million by 2022
The global digital pathology market is projected to grow at a CAGR of 8.5% from 2017-2022 to reach USD 600 million by 2022, despite the presence of headwinds that are suppressing market potential and limiting its growth.
Read More
07 Feb 2019
Puritan Medical Products Kicks Off 100th Anniversary Celebrations
Puritan Medical Products Co. LLC, a global manufacturer of single-use products, is all set to celebrate its 100th anniversary this year.
Read More
07 Feb 2019
New AI System Prioritizes Chest X-Rays Containing Critical Findings
A team of UK researchers has trained an artificial intelligence (AI) system to interpret and prioritize abnormal chest X-rays with critical findings, thereby creating the potential for reducing the backlog of exams and bringing urgently needed care to patients more quickly.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions